Breaking Biotech

Portfolio

Lists

Sources

Guide

How would you rate this source in terms of content quality?

Similiar Sources

121 Mining Investment TV

Materials - Analysis 8.0

7investing

Generalists - Analysis 8.0

a16z

Venture Capital - Analysis 9.0

Americas Market Intelligence

Emerging Markets - Analysis 9.0

ARK Invest

Tech - Analysis 8.5

BioCentury This Week

Biotech - Analysis 8.0

Biotech Hangout - Spotify

Biotech - Analysis 8.0

BioTech Nation ... with Dr. Moira Gunn

Biotech - Analysis 8.0

Business Of Biotech

Biotech - Analysis 8.0

CRISPR Investors

Biotech - Analysis 8.0

Summary

Sector Biotech

Content Type Analysis

Website YouTube

Paywall No

Ratings

Average Rating 9.0

Ratings 1

Your Rating Rate

Ranking 105

Content

Breaking Biotech

113 - Vaxxinity Takes on Neurodegenerative Diseases with Vaccines - Potential Short Opportunity?

May 8, 2022, 11 p.m.

No Paywall

Breaking Biotech

112 - Biotech Updates - $BTAI $TGTX $CRIS $CKPT $KPTI $SRRA

April 21, 2022, 12:15 a.m.

No Paywall

Breaking Biotech

111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich

April 1, 2022, 8:24 p.m.

No Paywall

Breaking Biotech

110 - Kodiac Sciences FALLS on Negative Wet AMD Readout! Buying Opportunity or Falling Knife??

March 5, 2022, 7:04 p.m.

No Paywall

Breaking Biotech

109 - Karyopharm Guides INCREASED Sales Growth in 2022 and Reports Positive SIENDO Results

Feb. 22, 2022, 5:06 p.m.

No Paywall

Breaking Biotech

Breaking Biotech Live Stream

Feb. 21, 2022, 7:15 p.m.

No Paywall

Breaking Biotech

108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD

Feb. 8, 2022, 12:13 a.m.

No Paywall

Breaking Biotech

107 - CymaBay Sets to Massively Improve Outcomes in PBC Patients | Interview with CEO Sujal Shah

Jan. 29, 2022, 4:15 p.m.

No Paywall

Breaking Biotech

106 - Bright Spot Among CRISPR in Caribou Biosci. 2022 Biotech Trends to Watch!

Jan. 9, 2022, 4:32 p.m.

No Paywall

Breaking Biotech

105 - Neurodegenerative Disease Recap! ALXO and LGVN updates plus Breaking Breaking 2021 Top Trades

Dec. 25, 2021, 7:31 p.m.

No Paywall

Breaking Biotech

104 - Biotech Bear Market Offers SIGNIFICANT Opportunity in Oncology - CRIS! Longeveron Rises on ODD

Dec. 5, 2021, 11:10 p.m.

No Paywall

Breaking Biotech

103 - CD47 Companies FALL on New Data! Biogen Negativity Continues with Looming NCD Decision

Nov. 21, 2021, 10:45 p.m.

No Paywall

Breaking Biotech

102 - Arvinas' PIONEERING PROTAC Tech to Enhance Cancer Outcomes | Interview with CEO John Houston

Oct. 28, 2021, 2:31 p.m.

No Paywall

Breaking Biotech

101 - MAJOR wet AMD/DR SCS Updates from REGENXBIO and CLSD! FDMT XLRP data arrives

Oct. 17, 2021, 12:38 a.m.

No Paywall

Breaking Biotech

100 - Absci Leverages AI to Become the GOOGLE of Drug Discovery! Interview with CEO Sean McClain

Oct. 5, 2021, 2:19 p.m.

No Paywall

Breaking Biotech

099 - Abbvie Announces MASSIVE Interest in REGENXBIO's RGX-314! Readout coming next week

Sept. 27, 2021, 5:09 a.m.

No Paywall

Breaking Biotech

098 - CD47 Companies RETURN with Trillium Acquisition! Cassava Sciences DROPS on Accusations

Sept. 6, 2021, 11:51 p.m.

No Paywall

Breaking Biotech

097 - Tg Therapeutics Q2-2021 Earnings Update | Interview with Michael Weiss - CEO of $TGTX

Aug. 23, 2021, 3:22 p.m.

No Paywall

Breaking Biotech

096 - Q2-2021 Biotech Earnings - Commercial-Stage Biotech Suffers!

Aug. 15, 2021, 3:48 p.m.

No Paywall

Breaking Biotech

095 - Smid Cap Biotechs Take on Geographic Atrophy (Dry AMD) with MAJOR Readout This Fall

July 22, 2021, 4:06 p.m.

No Paywall

Breaking Biotech

094 - Checkpoint Therapeutics Targets MASSIVE Solid Tumor Market | Interview with CEO James Oliviero

July 4, 2021, 11:54 p.m.

No Paywall

Breaking Biotech

093 - Ophthalmology Gene Therapies STUMBLE but REGENXBIO and FDMT Could Turn it Around in H2-2021

June 28, 2021, 1:07 a.m.

No Paywall

Breaking Biotech

092 - Biotech Bears CRUSHED with Biogen's Aduhelm Approval! CRIS/REPL Decline on Data Updates

June 14, 2021, 2:07 a.m.

No Paywall

Breaking Biotech

091 - Annovis DOUBLES on Mixed Alzheimer's Disease Data. ASCO Abstracts Released!

June 2, 2021, 7:03 p.m.

No Paywall

Breaking Biotech

090 - Curis Shows Positive Data in AML with First in Class IRAK4 Inhibitor

May 18, 2021, 8:26 p.m.

No Paywall

1 - 25 of 50 Results

Add to your lists

Recommended Content